Hacker News new | ask | show | jobs
by ekianjo 862 days ago
its not disease prevention its correlation.
1 comments

Finding a novel correlate that precedes the other observed effects of the disease in question is progress in prevention.
people thought for years that amyloid plaques were driving the disease only to be proven utterly wrong

you might want to have a bit of humility when dealing with complex systems

Can you please not post in the flamewar style? You've broken the site guidelines here and we've already had to ask you not to do that.

https://news.ycombinator.com/newsguidelines.html

Edit: actually, since your recent comments look like this, I've banned the account:

https://news.ycombinator.com/item?id=39341879

https://news.ycombinator.com/item?id=39341602

https://news.ycombinator.com/item?id=39341585

https://news.ycombinator.com/item?id=39341578

https://news.ycombinator.com/item?id=39308894

https://news.ycombinator.com/item?id=39281272

https://news.ycombinator.com/item?id=39249635

https://news.ycombinator.com/item?id=39238628

https://news.ycombinator.com/item?id=39237978

That's completely unacceptable on HN. If you don't want to be banned, you're welcome to email hn@ycombinator.com and give us reason to believe that you'll follow the rules in the future.

Thank you for all of the work you do to keep this as civil a place one could possibly expect to find that’s open to the general public on the internet.
‘Utterly wrong’ is a harsh conclusion. You may want a touch of humility yourself. Amyloid plaques are the defining feature of AD and assuredly provide vital clues about the biomolecular processes driving AD across the brain. There is renewed interest in the what causative role amyloid plays [1]. Whether plaques are causative or a byproduct is an open question, especially when we consider the heterogeneity in neurodegenerative diseases. AD itself probably is an umbrella term capturing several subtypes (such as CAA). Whatever role amyloid plays, the OP is correct: correlates open interesting research avenues and this is an interesting paper if for no other reason we have few predictors of who will develop AD.

[1] https://www.nature.com/articles/s41392-023-01484-7

Hmm. Are you saying that the fact that some knowledge is wrong means that it doesn’t represent progress?

Correlation isn’t “cure” — we don’t even know if it’s predictive — but that doesn’t mean it’s not progress.

progress is measured by:

- identifying mechanism of action

- identifying therapeutic levers

- testing drugs and ahow that they can do something

we are not even at the first step with these biomarkers. observational studies are super noisy

How can you identify a mechanism of action if you don't have any idea of what the possible agents are? Don't you first have to identify some of the molecules that may be involved, before you figure out which ones are causal and how that causality plays out?

That seems to be the point of this paper.

I agree with you. I think being proven utterly wrong is a huge accomplishment nonetheless. We shouldn’t be sure of ourselves, but we should treasure any progress even if it’s in the form of negating causes rather than isolating them.